» Authors » Sreenivasa Rao Kondapally Seshasai

Sreenivasa Rao Kondapally Seshasai

Explore the profile of Sreenivasa Rao Kondapally Seshasai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 4128
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ray K, Pillas D, Hadjiphilippou S, Khunti K, Seshasai S, Vallejo-Vaz A, et al.
Am J Prev Cardiol . 2023 Sep; 15:100580. PMID: 37727649
Background: Familial hypercholesterolemia (FH) is common, but underdiagnosed, and few systematic early screening programs exist. Objective: To assess health outcomes among those with a recorded diagnosis of FH and potential...
2.
Kralj-Hans I, Li K, Wesek A, Lamorgese A, Omar F, Ranasinghe K, et al.
BMJ Open . 2023 Apr; 13(4):e068179. PMID: 37055207
Objective: To evaluate the clinical efficacy and safety of leflunomide (L) added to the standard-of-care (SOC) treatment in COVID-19 patients hospitalised with moderate/critical clinical symptoms. Design: Prospective, open-label, multicentre, stratified,...
3.
Ng S, Pan J, Mouyis K, Seshasai S, Kapil V, Rice K, et al.
Front Cardiovasc Med . 2022 May; 9:871151. PMID: 35557537
Background: More than 80% of individuals in low and middle-income countries (LMICs) are unvaccinated against coronavirus disease 2019 (COVID-19). In contrast, the greatest burden of cardiovascular disease is seen in...
4.
5.
Dharmayat K, Woringer M, Mastellos N, Cole D, Car J, Ray S, et al.
JMIR Res Protoc . 2020 Oct; 9(10):e17548. PMID: 33006568
Background: Global trends in cardiovascular disease (CVD) exhibit considerable interregional and interethnic differences, which in turn affect long-term CVD risk across diverse populations. An in-depth understanding of the interplay between...
6.
Dowling C, Seshasai S, Firoozi S, Brecker S
Catheter Cardiovasc Interv . 2019 Oct; 96(1):158-166. PMID: 31566902
Objectives: We wished to undertake a reconstructed individual patient data meta-analysis of randomized clinical trials comparing transcatheter aortic valve replacement (TAVR) and surgery for patients with severe symptomatic aortic stenosis....
7.
Khunti K, Danese M, Kutikova L, Catterick D, Sorio-Vilela F, Gleeson M, et al.
JAMA Netw Open . 2019 Jan; 1(8):e185554. PMID: 30646277
Importance: Both adherence and treatment intensity can alter the effectiveness of lipid-lowering therapy in routine clinical practice. Objective: To evaluate the association of adherence and treatment intensity with cardiovascular outcomes...
8.
Seshasai S, Kaski J
Eur Cardiol . 2018 Nov; 12(1):24-25. PMID: 30416546
No abstract available.
9.
Isekame Y, Gati S, Aragon-Martin J, Bastiaenen R, Seshasai S, Child A
Eur Cardiol . 2018 Oct; 11(2):102-110. PMID: 30310455
Marfan syndrome (MFS) is a disease in which connective tissue becomes weak secondary to fibrillin-1 mutations, resulting in aortic dilatation, aneurysm formation, aortic dissection, aortic regurgitation and mitral valve prolapse....
10.
Ciliberti G, Seshasai S, Ambrosio G, Kaski J
Int J Cardiol . 2017 Jun; 244:77-83. PMID: 28622945
Aims: Systematic review of literature to evaluate safety of intracoronary (i.c.) pharmacologic testing with acetylcholine (ACh), or ergonovine (ERGO), to induce coronary artery spasm. Methods And Results: Review of all...